Skip to main content

Sanofi 6-K, filed Oct 26, 2026

Sanofi (SNY)

6-K 2026-10-26 For: 2026-10-26
View Original
Added on October 26, 2026

About this 6-K

Sanofi filed this 6-K on October 26, 2026.

Sanofi broke ground on a new insulin manufacturing facility at its Frankfurt BioCampus in Germany. Full insulin active pharmaceutical ingredient production is planned for 2032, once the facility is fully licensed. AI summary